Browsing Tag
Memorial Sloan Kettering Cancer Center
6 posts
Why did Sellas Life Sciences file to register 19.69m shares, and how could this affect SLS stock performance in 2025?
Sellas registers 19.69 M shares for resale after a warrant deal. Discover what it means for dilution, stock sentiment, and upcoming biotech catalysts.
Precision Cell Systems consolidates cell analysis tech through dual acquisitions to serve 700+ research customers
Discover how Precision Cell Systems is consolidating cell analysis tech through key acquisitions to serve 700+ research customers globally.
Y-mAbs Therapeutics showcases promising CD38-SADA translational pharmacokinetics data at AACR 2025
Find out how Y-mAbs’ CD38-SADA translational pharmacokinetics study at AACR 2025 is advancing next-gen cancer therapies with promising clinical insights.
Memorial Sloan Kettering Cancer Center partners with AWS to advance AI-driven cancer research
Memorial Sloan Kettering Cancer Center has joined forces with Amazon Web Services, an Amazon.com, Inc. company, to leverage…
Lilly bags Retevmo FDA approval for RET-driven lung and thyroid cancers
Retevmo FDA approval : Eli Lilly and Company (Lilly) has secured approval from the US Food and Drug…
Y-mAbs begins roll-out of BLA of naxitamab to FDA for neuroblastoma
US biopharma company Y-mAbs Therapeutics has submitted the first portions of its biologics license application (BLA) for naxitamab…